Carvedilol Tablet, Film Coated
Product Images NDC 82804-225

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Carvedilol (NDC 82804-225). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula For Carvedilol (Image 1)

Chemical structure of Carvedilol, the active ingredient shown in the image. The diagram depicts the molecular arrangement including rings, hydroxyl group (OH), methoxy group (OCH3), and amine functional groups as part of the compound's structure.*

FDA Label Image

Fig 1 (Image 2)

A line graph depicting cumulative percent mortality over a 21-month period comparing Carvedilol and placebo groups. The x-axis represents months, ranging from 0 to 21, and the y-axis shows percent mortality from 0 to 30%. Two lines demonstrate lower mortality for the Carvedilol group versus placebo, with a significance value (P = 0.0014).*

FDA Label Image

Fig 2 (Image 3)

A forest plot showing hazard ratios across various patient subgroups including sex (men, women), age (< 65, ≥ 65), race (non-black, black), diabetic status, ischemic condition, heart rate categories, systolic blood pressure categories, and spironolactone use. Each subgroup is represented by a point estimate with confidence intervals, plotted against a hazard ratio scale from 0.0 to 2.0.*

FDA Label Image

Fig 3 (Image 4)

A line graph depicting percent mortality over a 24-month period, comparing two groups labeled as "Placebo" and "Carvedilol." The graph shows mortality percentage on the vertical axis and months on the horizontal axis, with a p-value of 0.03 indicating statistical significance between the two groups.*

FDA Label Image

Fig 4 (Image 5)

This figure is a hazard ratio forest plot displaying subgroup analyses for a clinical study involving Carvedilol. It compares hazard ratios for different patient subgroups including age, gender, timing post-myocardial infarction, prior beta-blocker use, Killip class, thrombolytic therapy, PTCA use, presence of congestive heart failure, diuretic use, angina, hypertension, diabetes, heart rate, and systolic blood pressure. Hazard ratios are shown with confidence intervals on a scale from 0.4 to 1.3.*

FDA Label Image

82804-225-90 (Image 8)

Carvedilol 12.5 mg tablets packaging label by Proficient Rx LP. The label indicates each film-coated tablet contains 12.5 mg carvedilol, USP, with 90 tablets per bottle. Tablets are described as white, film-coated, elliptical-shaped, debossed with "TV" on one side and "7295" on the other. Manufactured in India by Piramal Pharma Limited. Storage instructions and NDC 82804-225-90 are shown.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.